Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
3.875
+0.165 (4.45%)
Nov 6, 2025, 1:29 PM EST
Raia Drogasil Market Cap
Raia Drogasil has a market cap or net worth of $6.45 billion as of November 6, 2025. Its market cap has decreased by -15.01% in one year.
Market Cap
6.45B
Enterprise Value
7.88B
Revenue
7.93B
Ranking
n/a
PE Ratio
25.63
Stock Price
$3.88
Market Cap Chart
Since November 26, 2008, Raia Drogasil's market cap has increased from 261.61M to 6.45B, an increase of 2,367.33%. That is a compound annual growth rate of 20.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 6.45B | 6.63% |
| Dec 30, 2024 | 6.05B | -41.88% |
| Dec 28, 2023 | 10.42B | 39.73% |
| Dec 29, 2022 | 7.45B | 3.88% |
| Dec 30, 2021 | 7.18B | -10.18% |
| Dec 30, 2020 | 7.99B | -12.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 666.34M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 305.39M |
| CytoDyn | 297.30M |